Webster Financial Corpora... (WBS)
NYSE: WBS
· Real-Time Price · USD
58.41
0.17 (0.29%)
At close: Aug 14, 2025, 3:59 PM
59.50
1.87%
After-hours: Aug 14, 2025, 07:48 PM EDT
0.29% (1D)
Bid | 57.28 |
Market Cap | 9.71B |
Revenue (ttm) | 4.27B |
Net Income (ttm) | 856.52M |
EPS (ttm) | 4.92 |
PE Ratio (ttm) | 11.87 |
Forward PE | 8.49 |
Analyst | Buy |
Ask | 61.72 |
Volume | 579,784 |
Avg. Volume (20D) | 1,403,148 |
Open | 57.53 |
Previous Close | 58.24 |
Day's Range | 57.14 - 58.44 |
52-Week Range | 39.43 - 63.99 |
Beta | 1.02 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WBS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Webster Financial Corporation is scheduled to release its earnings on
Oct 16, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+6.2%
Shares of banking and financial services stocks ar...
Unlock content with
Pro Subscription
3 months ago
+2.17%
Shares of financial companies are trading higher amid overall market strength after President Trump said he will not be firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be lower than the current one, which may lead to greater business and lending activity for financial institutions.

2 weeks ago · businesswire.com
Webster Financial Corporation Declares Common and Preferred DividendsSTAMFORD, Conn.--(BUSINESS WIRE)--Webster Financial Corporation (NYSE: WBS), the holding company for Webster Bank, N.A., announced that its Board of Directors declared a quarterly cash dividend of $0....

3 weeks ago · fool.com
Webster Financial EPS Jumps 48% in Q2Webster Financial EPS Jumps 48% in Q2

4 weeks ago · seekingalpha.com
Webster Financial Corporation (WBS) Q2 2025 Earnings Call TranscriptWebster Financial Corporation (NYSE:WBS ) Q2 2025 Earnings Conference Call July 17, 2025 9:00 AM ET Company Participants Emlen Briggs Harmon - Senior MD & Director of Investor Relations John R. Ciulla...